Variagenics

About:

Variagenics develops and commercializes proprietary gene variance detection technology to streamline drug development.

Website: https://variagenics.com

Top Investors: Goldman Sachs, Advent International, Atlas Venture, Forward Ventures, Oxford Bioscience Partners

Description:

Variagenics develops and commercializes proprietary gene variance detection technology to streamline drug development.

Total Funding Amount:

$19M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

1992-01-01

Founders:

Number of Employees:

Last Funding Date:

2000-03-17

IPO Status:

Private

Industries: